Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Clinical trial NCT05764356 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05764356
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Novel Oral Anticoagulants NOACs Rivaroxaban Apixaban Edoxaban Dabigatran Ticagrelor Pharmacodynamics Pharmacogenomics RNA Profile Bleeding Biomarker

Start date: 2023-03-01
Primary completion: 2026-12-01
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.